These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 9372685)
1. Airway responsiveness in transgenic mice overexpressing platelet-activating factor receptor. Roles of thromboxanes and leukotrienes. Nagase T; Ishii S; Katayama H; Fukuchi Y; Ouchi Y; Shimizu T Am J Respir Crit Care Med; 1997 Nov; 156(5):1621-7. PubMed ID: 9372685 [TBL] [Abstract][Full Text] [Related]
2. Airway hyperresponsiveness in transgenic mice overexpressing platelet activating factor receptor is mediated by an atropine-sensitive pathway. Nagase T; Ishii S; Shindou H; Ouchi Y; Shimizu T Am J Respir Crit Care Med; 2002 Jan; 165(2):200-5. PubMed ID: 11790655 [TBL] [Abstract][Full Text] [Related]
3. Prostaglandins, leukotrienes and PAF selectively modulate lymphocyte subset and eosinophil infiltration into the airways in a murine model of asthma. Landgraf RG; Nossi DF; Sirois P; Jancar S Prostaglandins Leukot Essent Fatty Acids; 2007; 77(3-4):163-72. PubMed ID: 17923399 [TBL] [Abstract][Full Text] [Related]
4. Partial agonist effect of the platelet-activating factor receptor antagonists, WEB 2086 and WEB 2170, in the rat perfused heart. Hu W; McNicholl IK; Choy PC; Man RY Br J Pharmacol; 1993 Oct; 110(2):645-50. PubMed ID: 8242237 [TBL] [Abstract][Full Text] [Related]
5. [The role of lipid mediators in bronchial hyperresponsiveness and airway eosinophil accumulation induced by antigen challenge in guinea pigs]. Tachibana H Arerugi; 2000 Aug; 49(8):634-45. PubMed ID: 11021015 [TBL] [Abstract][Full Text] [Related]
6. Synergistic effects of pranlukast and leukotriene B4 receptor antagonist on antigen-induced pulmonary reaction. Sakurada T; Abe M; Kodani M; Sakata N; Katsuragi T Eur J Pharmacol; 1999 Apr; 370(2):153-9. PubMed ID: 10323264 [TBL] [Abstract][Full Text] [Related]
7. Suppressive effects of Y-24180, a receptor antagonist to platelet activating factor (PAF), on antigen-induced asthmatic responses in guinea pigs. Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Matsuura M; Kawakami Y; Terasawa M Inflamm Res; 1997 Apr; 46(4):147-53. PubMed ID: 9137994 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological studies of platelet-activating factor (PAF)-induced augmentation of response to histamine in guinea-pigs. Sakurai T; Yamaguchi S; Iwama T; Nagai H Prostaglandins Leukot Essent Fatty Acids; 1994 Aug; 51(2):95-9. PubMed ID: 7972272 [TBL] [Abstract][Full Text] [Related]
9. A role for phospholipid-derived inflammatory mediators in intestinal anaphylaxis in the rat. MacNaughton WK; Catto-Smith AG; Gall DG J Pharmacol Exp Ther; 1992 Feb; 260(2):773-9. PubMed ID: 1738123 [TBL] [Abstract][Full Text] [Related]
10. Immune-complex alveolitis in the rat: evidence for platelet activating factor and leukotrienes as mediators of the vascular lesions. de Lima WT; Sirois P; Jancar S Eur J Pharmacol; 1992 Mar; 213(1):63-70. PubMed ID: 1323472 [TBL] [Abstract][Full Text] [Related]
11. Hypoxic pulmonary vasoconstriction in isolated blood-perfused rat lung; modulation by thromboxane A2, platelet-activating factor, cysteinyl leukotrienes and endothelin-1. Chłopicki S; Bartuś JB; Gryglewski RJ Pol J Pharmacol; 2002; 54(5):433-41. PubMed ID: 12593530 [TBL] [Abstract][Full Text] [Related]
12. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action. Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Kawakami Y; Terasawa M Pharmacology; 1997 May; 54(5):261-70. PubMed ID: 9380772 [TBL] [Abstract][Full Text] [Related]
13. Interaction of vasoactive substances released by platelet-activating factor in the rat perfused heart. Hu WM; Man RY Br J Pharmacol; 1991 Dec; 104(4):933-7. PubMed ID: 1810604 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of platelet-activating factor-induced lipid body formation: requisite roles for 5-lipoxygenase and de novo protein synthesis in the compartmentalization of neutrophil lipids. Bozza PT; Payne JL; Goulet JL; Weller PF J Exp Med; 1996 Apr; 183(4):1515-25. PubMed ID: 8666909 [TBL] [Abstract][Full Text] [Related]
15. Cysteinyl-leukotrienes partly mediate eotaxin-induced bronchial hyperresponsiveness and eosinophilia in IL-5 transgenic mice. Hisada T; Salmon M; Nasuhara Y; Chung KF Am J Respir Crit Care Med; 1999 Aug; 160(2):571-5. PubMed ID: 10430730 [TBL] [Abstract][Full Text] [Related]
16. Modulation by lipid mediators of immune complex-induced lung inflammation in mice. Steil AA; Tavares de Lima W; Jancar S Eur J Pharmacol; 1998 Nov; 361(1):93-9. PubMed ID: 9851546 [TBL] [Abstract][Full Text] [Related]
17. Contributions of thromboxane and leukotrienes to PAF-induced impairment of lung function in the rat. Uhlig S; Wollin L; Wendel A J Appl Physiol (1985); 1994 Jul; 77(1):262-9. PubMed ID: 7961243 [TBL] [Abstract][Full Text] [Related]
18. Mesenteric microvascular inflammatory responses to systemic hypoxia are mediated by PAF and LTB4. Casillan AJ; Gonzalez NC; Johnson JS; Steiner DR; Wood JG J Appl Physiol (1985); 2003 Jun; 94(6):2313-22. PubMed ID: 12598480 [TBL] [Abstract][Full Text] [Related]
19. Antagonism of vasoconstriction induced by platelet-activating factor in guinea-pig perfused hearts by selective platelet-activating factor receptor antagonists. Piper PJ; Stewart AG Br J Pharmacol; 1987 Apr; 90(4):771-83. PubMed ID: 3034369 [TBL] [Abstract][Full Text] [Related]
20. Role of leukotrienes and platelet activating factor in allergic bronchoconstriction and their interactions in guinea pig airway in vivo. Saito M; Fujimura M; Ogawa H; Matsuda T Prostaglandins Leukot Essent Fatty Acids; 1993 Aug; 49(2):579-85. PubMed ID: 8415807 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]